|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,835.00 KRW | +7.27% |
|
-19.18% | -44.26% |
| 14/04 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| 03/04 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +7.27% | -19.18% | -37.34% | -59.97% | -44.26% | +35.04% | -54.56% | -80.53% | - | 112M | |
| +1.17% | +5.86% | +9.92% | +9.43% | +1.41% | -3.47% | +2.25% | -16.83% | +238.34% | 46.62B | |
| +5.79% | +16.17% | +22.31% | +108.22% | +141.83% | +421.86% | +634.63% | +503.07% | - | 40.95B | |
| +1.12% | +15.18% | +6.08% | +17.96% | -14.25% | +22.74% | -12.71% | -20.82% | +204.43% | 32.26B | |
| +3.61% | +6.69% | +0.72% | +2.46% | -4.55% | +20.23% | +62.38% | -18.79% | +865.67% | 32.24B | |
| +8.02% | +6.35% | -2.46% | -8.66% | +3.96% | +17.67% | +34.73% | -17.75% | +170.14% | 25.53B | |
| +1.13% | +15.66% | +17.67% | - | - | - | - | - | - | 16.38B | |
| +1.45% | +17.35% | +19.59% | +18.51% | -4.79% | +72.11% | +127.60% | +201.17% | - | 15.27B | |
| +0.18% | +4.69% | +10.41% | +8.90% | +9.46% | +13.00% | +17.43% | -29.15% | +104.74% | 13.61B | |
| -0.60% | +6.32% | +5.48% | +11.84% | +2.00% | +102.74% | +96.28% | +104.02% | +248.55% | 13.34B | |
| +1.84% | +22.92% | +27.13% | +69.47% | -5.07% | +19.67% | -28.70% | -19.18% | +150.31% | 13.25B | |
| -0.14% | +27.50% | +37.19% | +39.16% | +20.56% | +36.77% | -10.65% | -36.67% | +160.23% | 11.05B | |
| +4.55% | +24.24% | +24.82% | +41.73% | +13.08% | +50.37% | +7.84% | -39.31% | +179.86% | 10.87B | |
| +3.87% | +21.86% | +15.53% | +36.81% | -1.25% | -12.34% | - | - | - | 10.47B | |
| +0.05% | +0.05% | +61.44% | +70.41% | +75.69% | +205.69% | - | - | - | 9.94B | |
| -4.63% | +14.15% | +24.51% | +78.73% | +87.74% | +82.33% | +67.67% | +116.17% | +20.79% | 8.76B | |
| +6.95% | +15.55% | +0.17% | +20.84% | +18.94% | +715.26% | +1,950.06% | +17.38% | - | 9.77B | |
| +1.11% | +9.92% | +34.27% | +39.87% | +40.50% | +147.78% | +388.04% | +156.38% | - | 8.99B | |
| +0.96% | +9.67% | +8.75% | +1.84% | -15.94% | -20.87% | -19.49% | -27.79% | +60.33% | 8.23B | |
| -0.88% | +1.08% | +15.65% | +60.59% | +51.49% | +139.19% | +107.94% | +256.57% | - | 7.91B | |
| Average | +1.97% | +11.99% | +15.09% | +29.90% | +19.82% | +108.72% | +198.28% | +61.64% | +218.49% | 16.78B | |
| Weighted average by Cap. | +2.38% | +12.78% | +14.50% | +32.90% | +25.32% | +108.73% | +185.66% | +85.18% | +283.18% |
- Stock Market
- Stocks
- A314130 Stock
- Sector Genome & Company
Select your edition
All financial news and data tailored to specific country editions
